Literature DB >> 9269226

FDA warns of potential protease-inhibitor link to hyperglycaemia.

A Ault.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9269226     DOI： 10.1016/S0140-6736(05)61703-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  New-onset diabetes mellitus associated with protease inhibitor therapy in an HIV-positive patient: case report and review.

Authors:  E C Lee; S Walmsley; I G Fantus
Journal:  CMAJ       Date:  1999-07-27       Impact factor: 8.262

Review 2.  Indinavir: a review of its use in the management of HIV infection.

Authors:  G L Plosker; S Noble
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

Review 3.  [Adverse effects of antiretroviral therapy. Aspects of pathogenesis].

Authors:  U Seybold; R Draenert; F D Goebel
Journal:  Internist (Berl)       Date:  2003-06       Impact factor: 0.743

Review 4.  Saquinavir soft-gel capsule formulation. A review of its use in patients with HIV infection.

Authors:  C M Perry; S Noble
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

5.  Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin.

Authors:  P H Hsyu; M D Schultz-Smith; J H Lillibridge; R H Lewis; B M Kerr
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.